Oct 26, 2021Completion of Enrollment in 1st US Clinical Trial & Achievement of 1st Primary ObjectiveJERUSALEM, Oct. 25, 2021 -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha...
Oct 12, 2021Alpha Tau Receives FDA's Breakthrough Device Designation for the Treatment of Recurrent GBMJERUSALEM, Oct. 8, 2021 -- Alpha Tau Medical, the developer of the innovative alpha-radiation cancer therapy Alpha DaRTâ„¢, is pleased to...
Jul 11, 2021Alpha Tau & Healthcare Capital Corp. to Combine and Create A $1-Billion Publicly Traded Company Alpha Tau and Healthcare Capital Corp. to Combine and Create A Publicly Traded Company Focused on Transforming the Treatment of Solid...
Jul 8, 2021First Alpha DaRT Patient Treated in the US as Part of Pilot Multicenter Skin Cancer TrialJerusalem, Israel, July 6, 2021 - Alpha Tau Medical, the developer of the pioneering alpha-radiation cancer therapy Alpha DaRTTM,...
Jun 13, 2021Alpha Tau Receives Breakthrough Device Designation from the FDA for Alpha DaRTâ„¢JERUSALEM, June 8, 2021 /PRNewswire/ -- Alpha Tau Medical, the developer of the pioneering alpha-radiation cancer therapy Alpha DaRT,TM...